LIC shares can rally up to 30%; check target prices of 5 brokerages (2024)

Brokerages are largely positive on LIC's future as they see an upside potential of up to 30% in the stock, suggesting target prices as high as Rs 1,300.

LIC had reported a net profit of Rs 13,782 crore for the quarter ended March 31, 2024, which was up by 4.5% YoY.

Here are the target prices given by various brokerage firms:

Kotak Institutional Equities

KIE states that while core VNB inches up, stock performance remains leveraged to rally in the capital market.

Kotak has a 'buy' rating with a target price of Rs 1,300 for the stock.

Religare Broking

The domestic brokerage firm stated that LIC is focused on increasing its agency channel along with focusing on the launch of the super app and has announced a foray into the health insurance business which remains a competitive market.

Religare has upgraded the stock to 'buy' with a target price of Rs 1,232.

JM Financial

"With the articulated focus on growth, we see this share to inch up only gradually from these levels. Topline growth would be led by its strong agency channel and should be aided by repricing of employee liabilities in its group segment," said JM Financial.

JM Financial maintained a 'buy' with an unchanged target price of Rs 1,222 for the stock.

Emkay Global

The corporation’s strategy towards increasing its share of Non-par products tracked

well, driven by the launch of new products. Further, with expectations of the introduction of a composite license, the management plans to acquire a health insurer, to capture the opportunities in the health insurance segment. Emkay Global has an 'add' rating on the stock with a target price of Rs 1,200.

Goldman Sachs

The global brokerage firm said that LIC's business mix is heading in the right direction, but the margin trajectory remains gradual. Further, the management also expects non-par products to outpace the rest of the top-line growth, leading to steady improvement in the value of new business (VNB) margins.

Goldman maintained a 'neutral' rating on the stock with a target price of Rs 950.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)